Jupiter Life Line Hospitals IPO will open for subscription from 06 September 2023. The company aims for an issue size of ₹869.08 Cr through this IPO.
Company Overview
Full name | Jupiter Life Line Hospitals Limited |
Sector | Healthcare |
Industry | Hospital & Healthcare Services |
Company Website | https://www.jupiterhospital.com/ |
About Company

Jupiter Life Line Hospitals is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India with a total bed capacity of 1,194 hospital beds across three hospitals as of 31 March 2023.
The company has been operating for over 15 years as a corporate quaternary care healthcare service provider in densely populated micro markets in the western regions of India and currently operates three hospitals under the “Jupiter” brand in Thane, Pune, and Indore, with an operational bed capacity of 950 beds and 961 beds, as of 31 March 2023, and 1,306 doctors including specialists, physicians, and surgeons, as of 31 March 2023. It is also currently in the process of developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.
The company’s inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.
The Objective of the Issue
- Repayment/pre-payment, in full or part, of borrowings availed from banks by the company and Material Subsidiary.
- General corporate purposes.
IPO Timetable
IPO Opening date | 06 September 2023 |
IPO Closing | 08 September 2023 |
Basis of Allotment | 13 September 2023 |
Initiation Refund | 14 September 2023 |
Credit to Demat Account | 15 September 2023 |
Listing Date | 18 September 2023 |
IPO details
Issue type | Book Built Issue IPO |
IPO issue size | ₹869.08 Cr – 11,824,163 shares |
Fresh Issue | ₹542.00 Cr – 7,374,163 shares |
Offer for sale | ₹327.08 Cr – 4,450,000 shares |
Face value | ₹10 per share |
Price Band | ₹695 to ₹735 per share |
Lot size | 20 Shares |
Retail Allocation | 35% |
Listing Exchange | BSE & NSE |
IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 20 | ₹14,700 |
Retail (Max) | 13 | 260 | ₹191,100 |
S-HNI (Min) | 14 | 280 | ₹205,800 |
S-HNI (Max) | 68 | 1,360 | ₹999,600 |
B-HNI (Min) | 69 | 1,380 | ₹1,014,300 |
Reservation Details
QIB Shares Offered | 50% |
NII (HNI) Shares Offered | 15% |
Retail Shares Offered | 35% |
Financial Performance
FY 2021 | FY 2022 | FY 2023 | |
Revenue | 486.16 | 733.12 | 892.54 |
Expenses | 488.71 | 659.83 | 772.05 |
Net income | (2.30) | 51.13 | 72.91 |
Margin (%) | 0.47 | 6.97 | 8.17 |
Valuations & Margins
FY 2021 | FY 2022 | FY 2023 | |
EPS | (0.45) | 9.65 | 12.95 |
PE ratio | – | – | 53.67 – 56.76 |
RONW (%) | (0.93) | 17.73 | 20.03 |
NAV | 48.45 | 56.70 | 64.39 |
ROCE (%) | 6.07 | 16.08 | 20.94 |
EBITDA (%) | 14.54 | 21.35 | 23.45 |
Debt/Equity | – | – | 1.29 |
Company Promoters
- Dr. Ajay Thakker
- Dr. Ankit Thakker
- Western Medical Solutions LLP
Promoter Holding
Pre Issue Share Holding | 40.69% |
Post Issue Share Holding | – |
Lead Manager(s)
- ICICI Securities Limited
- Nuvama Wealth Management Limited
- Jm Financial Limited
IPO Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: jupiterlife.ipo@kfintech.com
Website: www.kfintech.com
Contact Details
JUPITER LIFE LINE HOSPITALS LIMITED
Jupiter Hospital, Eastern Express Highway,
Thane (West), Mumbai – 400 601 Maharashtra, India
Phone: +91 22 2172 5623
E-mail: cs@jupiterhospital.com
Website: www.jupiterhospital.com
Allotment Status
Jupiter Life Line Hospitals IPO allotment will be available on the KFin Tech website. Click on this link to get allotment status.
Final thoughts
Jupiter Life Line Hospitals IPO is going to hit Dalal Street soon. applying for an IPO is purely a personal choice. study well about the company and subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.
Happy Investing